Also known as: blood disorders, hemic, lymphatic, anemia, leukemia, sickle cell, blood cancer, lymphoma
Have a specific question about Blood Disorders (Hemic/Lymphatic) Rating?
Ask Our AI AssistantFree. Answers cite their sources, such as 38 CFR, VA.gov and other veterans-benefits references.
Anemia occurs when there are insufficient healthy red blood cells in the bloodstream.
Primary anemia receives presumptive status if it manifests within one year of separation and warranted at least a 10% evaluation during that period.
Red blood cells become shaped like a sickle.
Service Connection Requirement: Veterans must have served in locations linked to the condition's cause, as sickle cell can result from genetic factors.
| Rating | Criteria |
|---|---|
| 10% | Symptoms resolved with established case in remission, with identifiable organ impairment |
| 30% | 1-2 painful episodes per 12 months |
| 60% | 3 painful episodes per 12 months OR symptoms preventing more than light manual labor |
| 100% | 4+ painful episodes per 12 months with anemia, thrombosis, and infarction; prevents light manual labor |
| Rating | Criteria |
|---|---|
| 10% | Requires continuous medication |
| 30% | Platelet/RBC transfusion at least once per 12 months OR infections recurring at least once per 12 months |
| 60% | Transfusion at least once every 3 months OR infections recurring at least once every 3 months OR continuous immunosuppressive therapy |
| 100% | Peripheral blood/bone marrow stem cell transplant OR transfusion at least once every 6 weeks OR infections recurring at least once every 6 weeks |
Camp Lejeune Presumptive Status: Veterans exposed to contaminated water who ever warranted 10%+ receive presumptive status.
Bone marrow not making enough new blood cells.
Important: The 100% rating for transplants continues 6 months post-hospitalization, followed by mandatory reevaluation.
Camp Lejeune Presumptive Status: Applies if exposed and severity ever warranted 10%+.
Pyramiding Note: When anemia results from blood loss caused by another condition, a secondary standalone rating is not permitted; it merges with the causative condition.
| Rating | Criteria |
|---|---|
| 0% | No symptoms or treatable through diet modification |
| 10% | Intravenous iron infusions 1-3 times per 12 months OR continuous oral supplements |
| 30% | Intravenous iron infusions 4+ times per 12 months |
Body cannot absorb sufficient vitamin B12.
Temporary 100% Rating: Continues 6 months after hospital discharge or parenteral B12 therapy completion, then mandatory reevaluation with 10% assignment if criteria no longer met.
| Rating | Criteria |
|---|---|
| 10% | Continuous B12 injections, sublingual tablets, high-dose oral forms, or nasal spray/gel |
| 100% | Initial diagnosis requiring transfusion for severe anemia OR CNS impairment signs (encephalopathy, myelopathy, severe neuropathy) requiring parenteral B12 |
Secondary Conditions: Individual ratings available for dementia, peripheral neuropathy, myelopathy, and related gastrointestinal issues.
Temporary 100% Rating: Bone marrow transplant rating continues 6 months post-discharge, followed by mandatory reevaluation.
| Rating | Criteria |
|---|---|
| 0% | No symptoms |
| 10% | 1 immunosuppressive therapy course per 12 months |
| 30% | 2-3 immunosuppressive therapy courses per 12 months |
| 60% | Immunosuppressive medication 4+ times per 12 months |
| 100% | Bone marrow transplant OR continuous IV/immunosuppressive therapy (prednisone, Cytoxan, azathioprine, rituximab) |
Bone marrow produces excess red blood cells.
Important Notes: - 100% rating is temporary, continuing 6 months after treatment, then mandatory reevaluation - Chemotherapy with myelosuppressants warrants 100% for 6 months post-treatment - If condition becomes cancerous, rated under Leukemia instead
| Rating | Criteria |
|---|---|
| 10% | Phlebotomy 3 or fewer times per 12 months OR intermittent biologic/interferon therapy maintaining reference ranges |
| 30% | Phlebotomy 4-5 times per 12 months OR continuous biologic/myelosuppressive agents maintaining platelets <200,000 or WBC <12,000 |
| 60% | Phlebotomy 6+ times per 12 months OR molecularly targeted therapy controlling RBC count |
| 100% | Stem cell transplant OR chemotherapy for symptom reduction |
Secondary Conditions: Individual ratings permitted for gout, hypertension, stroke, and thrombotic disease.
| Rating | Criteria |
|---|---|
| 0% | No symptoms or diet modification suffices |
| 10% | Continuous high-dose oral supplement treatment |
Bone marrow does not produce enough white blood cells.
Temporary 100% Rating: Continues 6 months post-transplant, followed by mandatory reevaluation.
| Rating | Criteria |
|---|---|
| 10% | Continuous medication (antibiotics) OR intermittent myeloid growth factor maintaining ANC >=1500/uL |
| 30% | Intermittent myeloid growth factors maintaining ANC >1000/uL OR infections recurring at least once per 12 months |
| 60% | Intermittent myeloid growth factors OR infections recurring at least once every 3 months per 12 months |
| 100% | Peripheral blood/bone marrow stem cell transplant OR transfusion/infection recurrence at least once every 6 weeks per 12 months |
Source: veteransbenefitskb.com
Need personalized guidance on Blood Disorders (Hemic/Lymphatic) Rating?
Ask Veterans Benefits AIAnswers cite their sources, so you can check them. AI can make mistakes.
Information from the Veterans Benefits Knowledge Base (veteransbenefitskb.com). Check the original source before you rely on it. Original source.
This page is for informational purposes only and is not legal or medical advice. AI-generated answers can contain errors.
Veterans Benefits AI is an independent 501(c)(3) nonprofit. It is not affiliated with or endorsed by the U.S. Department of Veterans Affairs.
© 2026 Veterans Benefits AI